mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.05 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.06 |